Truist Financial’s Microbot Medical MBOT Stock Holding History

Truist Financial’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,000	Closed	-$11.3K	–	2607
2024 Q4	$11.3K	Buy	+10,000	New	+$9.78K	﹤0.01%	2502

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Truist Financial's MBOT Position: Q1 2025 in Review

Truist Financial sold out of Microbot Medical (MBOT) in Q1 2025, closing a stake of 10,000 shares — an estimated $11.3K sold.

Truist Financial first reported a position in MBOT in Q4 2024 and held it in 1 quarter. The position peaked at $11.3K in Q4 2024. 43 funds tracked by Wall St. Rank hold MBOT as of Q1 2025.

Truist Financial reported no remaining Microbot Medical position as of Q1 2025 after selling out during the quarter.
Truist Financial sold 10,000 Microbot Medical shares in Q1 2025, an estimated $11.3K.
Truist Financial first reported a position in Microbot Medical in Q4 2024 and held it in 1 quarter.
Truist Financial's Microbot Medical position peaked at $11.3K in Q4 2024.
43 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2025.

Based on Truist Financial's 13F filing for Q1 2025, filed 29 Apr 2025.